241 related articles for article (PubMed ID: 1610407)
1. In vitro protection of acetylcholinesterase and butyrylcholinesterase by tetrahydroaminoacridine. Comparison with physostigmine.
Galli A; Mori F; Gori I; Lucherini M
Biochem Pharmacol; 1992 Jun; 43(11):2427-33. PubMed ID: 1610407
[TBL] [Abstract][Full Text] [Related]
2. In-vitro and in-vivo protection of acetylcholinesterase by eseroline against inactivation by diisopropyl fluorophosphate and carbamates.
Galli A; Malmberg Aiello P; Renzi G; Bartolini A
J Pharm Pharmacol; 1985 Jan; 37(1):42-8. PubMed ID: 2858526
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of 1,2,3,4-tetrahydro-9-aminoacridine (THA) as a pretreatment drug for protection of mice from acute diisopropylfluorophosphate (DFP) intoxication.
Galli A; Mori F
Arch Toxicol; 1991; 65(4):330-4. PubMed ID: 1953352
[TBL] [Abstract][Full Text] [Related]
4. Prevention of physostigmine-induced lethality by the opioid analgesic meptazinol in the mouse.
Bottoncetti A; Galli A
Br J Pharmacol; 1987 Jun; 91(2):299-306. PubMed ID: 3607358
[TBL] [Abstract][Full Text] [Related]
5. Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum.
Clarke PB; Reuben M; el-Bizri H
Br J Pharmacol; 1994 Mar; 111(3):695-702. PubMed ID: 8019748
[TBL] [Abstract][Full Text] [Related]
6. Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase.
Berman HA; Leonard K
Mol Pharmacol; 1992 Feb; 41(2):412-8. PubMed ID: 1538717
[TBL] [Abstract][Full Text] [Related]
7. Tacrine protection of acetylcholinesterase from inactivation by diisopropylfluorophosphate: a circular dichroism study.
Wu CS; Yang JT
Mol Pharmacol; 1989 Jan; 35(1):85-92. PubMed ID: 2913485
[TBL] [Abstract][Full Text] [Related]
8. Protection against diisopropylfluorophosphate intoxication by meptazinol.
Galli A; Mazri A
Toxicol Appl Pharmacol; 1988 Sep; 95(3):388-96. PubMed ID: 3188007
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cholinesterase-associated aryl acylamidase activity by anticholinesterase agents: focus on drugs potentially effective in Alzheimer's disease.
Costagli C; Galli A
Biochem Pharmacol; 1998 May; 55(10):1733-7. PubMed ID: 9634011
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cholinesterase activity by tetrahydroaminoacridine and the hemisuccinate esters of tocopherol and cholesterol.
Chelliah J; Smith JD; Fariss MW
Biochim Biophys Acta; 1994 May; 1206(1):17-26. PubMed ID: 8186246
[TBL] [Abstract][Full Text] [Related]
11. Protection of acetylcholinesterase by meptazinol in mice exposed to di-isopropyl fluorophosphate. Comparison with physostigmine.
Galli A; Mori F
J Pharm Pharmacol; 1991 May; 43(5):366-9. PubMed ID: 1680183
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors.
Lorke DE; Hasan MY; Nurulain SM; Shafiullah M; Kuča K; Petroianu GA
J Appl Toxicol; 2011 Aug; 31(6):515-23. PubMed ID: 20981864
[TBL] [Abstract][Full Text] [Related]
13. Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro.
Ogura H; Kosasa T; Kuriya Y; Yamanishi Y
Methods Find Exp Clin Pharmacol; 2000 Oct; 22(8):609-13. PubMed ID: 11256231
[TBL] [Abstract][Full Text] [Related]
14. Phosphoacetylcholinesterase: toxicity of phosphorus oxychloride to mammals and insects that can be attributed to selective phosphorylation of acetylcholinesterase by phosphorodichloridic acid.
Quistad GB; Zhang N; Sparks SE; Casida JE
Chem Res Toxicol; 2000 Jul; 13(7):652-7. PubMed ID: 10898598
[TBL] [Abstract][Full Text] [Related]
15. Species- and concentration-dependent differences of acetyl- and butyrylcholinesterase sensitivity to physostigmine and neostigmine.
Bitzinger DI; Gruber M; Tümmler S; Michels B; Bundscherer A; Hopf S; Trabold B; Graf BM; Zausig YA
Neuropharmacology; 2016 Oct; 109():1-6. PubMed ID: 26772968
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological significance of acetylcholinesterase inhibition by tetrahydroaminoacridine.
Marquis JK
Biochem Pharmacol; 1990 Sep; 40(5):1071-6. PubMed ID: 2390104
[TBL] [Abstract][Full Text] [Related]
17. Effects of diisopropylfluorophosphate on brain acetylcholinesterase, butyrylcholinesterase, and neurotoxic esterase in rats.
Lim DK; Hoskins B; Ho IK
Biomed Environ Sci; 1989 Sep; 2(3):295-304. PubMed ID: 2610946
[TBL] [Abstract][Full Text] [Related]
18. The nature of the inhibition of camel retina acetylcholinesterase (EC 3.1.1.7) activity by tetrahydroaminoacridine.
al-Jafari AA
J Ocul Pharmacol Ther; 1996; 12(4):503-14. PubMed ID: 8951687
[TBL] [Abstract][Full Text] [Related]
19. Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain.
Rakonczay Z
Acta Biol Hung; 2003; 54(2):183-9. PubMed ID: 14535624
[TBL] [Abstract][Full Text] [Related]
20. Potency of several oximes to reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by paraoxon in vitro.
Jun D; Musilova L; Kuca K; Kassa J; Bajgar J
Chem Biol Interact; 2008 Sep; 175(1-3):421-4. PubMed ID: 18617161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
